Plain-English translation of NCT02844764 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new treatment called StroMed, which uses your own cells collected from fatty tissue, along with platelet-rich plasma (PRP) from your blood. Both are injected directly into your hip joint to reduce pain and swelling from osteoarthritis. The study will track whether this treatment is safe and whether it helps reduce pain, improve mobility, and possibly delay or prevent hip replacement surgery.
Hip arthritis can be very painful and limit what you can do in daily life. Current treatments like pain medication and physical therapy don't work for everyone. This trial exists to see if using your own cells—which have natural healing properties—might offer a safer alternative that reduces pain without the risks of surgery or long-term medication.
You likely qualify if…
You likely don't qualify if…
You will have cells collected from your fatty tissue using a special ultrasound device, and your blood will be processed to make platelet-rich plasma. These will then be injected into your affected hip joint. You'll have follow-up visits over 6 months that include blood tests, imaging scans (MRI), questionnaires about your pain and function, and quality-of-life surveys. The trial will track whether your pain improves, how well you move, and whether you might be able to avoid or delay hip replacement surgery.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
United States